Projects funded by the NCN


Information on the principal investigator and host institution

Information of the project and the call

Keywords

Equipment

Delete all

Search results

105 projects found matching your search criteria :

  1. The impact of early-life stress (maternal separation) and fluctuation in corticosterone levels during adolescence on pre...

    Call: PRELUDIUM 9 , Panel: NZ4

    Principal investigator: Iwona Majcher-Maślanka

    Instytut Farmakologii PAN

  2. Injectable biodegradable local drug delivery system supramolecularly cross-linked in situ with controlled drug release

    Call: OPUS 9 , Panel: ST5

    Principal investigator: dr hab. Piotr Kurcok

    Centrum Materiałów Polimerowych i Węglowych PAN

  3. The role of expectancy and anxiety in the genesis of placebo analgesia and nocebo hyperalgesia induced by classical cond...

    Call: SONATA BIS 4 , Panel: HS6

    Principal investigator: dr hab. Przemysław Bąbel

    Uniwersytet Jagielloński, Wydział Filozoficzny

  4. Study of the influence of the drug physicochemical properties on its endothelial distribution and binding ability to pla...

    Call: PRELUDIUM 7 , Panel: NZ7

    Principal investigator: Anna Gonciarz-Dytman

    Uniwersytet Jagielloński, Jagiellońskie Centrum Rozwoju Leków (JCET)

  5. A longitudinal study of relationship status and the mental and physical health of young adults in Poland and in the Unit...

    Call: OPUS 7 , Panel: HS6

    Principal investigator: dr Katarzyna Adamczyk

    Uniwersytet im. Adama Mickiewicza w Poznaniu, Wydział Nauk Społecznych

  6. Estimation of surrogate of the effective drug concentration responsible for cardiac electrophysiological effect - numeri...

    Call: PRELUDIUM 7 , Panel: NZ7

    Principal investigator: Zofia Tylutki

    Uniwersytet Jagielloński - Collegium Medicum, Collegium Medicum, Wydział Farmaceutyczny

  7. The extension of consumer association and dissociation model - the role of anxiety, need of uniqueness and individual id...

    Call: PRELUDIUM 6 , Panel: HS6

    Principal investigator: Dariusz Drążkowski

    Uniwersytet im. Adama Mickiewicza w Poznaniu, Wydział Nauk Społecznych

  8. Synthesis and structural characterization of MCM-48/nano-HA/cytostatic drug composites

    Call: PRELUDIUM 6 , Panel: ST5

    Principal investigator: dr Łukasz Pajchel

    Warszawski Uniwersytet Medyczny, Wydział Farmaceutyczny z Oddziałem Medycyny Laboratoryjnej

  9. Novel peptide inhibitors of dipeptidyl peptidase IV (DPP IV) as novel approach for diabetes type 2 and inflammatory bowe...

    Call: PRELUDIUM 6 , Panel: NZ7

    Principal investigator: Maciej Sałaga

    Uniwersytet Medyczny w Łodzi, Wydział Lekarski

  10. New nanocarriers of curcumin as a kind of "pro-drug" - physicochemical characteristics and biological characteristics on...

    Call: PRELUDIUM 5 , Panel: ST5

    Principal investigator: dr Dorota Lachowicz

    Uniwersytet Jagielloński, Wydział Chemii

  11. Antidepressats as substances that increase the activity of risperidone, an atypical antipsychotic drug in animal models

    Call: PRELUDIUM 5 , Panel: NZ7

    Principal investigator: Katarzyna Kamińska

    Instytut Farmakologii PAN

  12. The mechanism of ligand binding and the conformational changes in the beta2-adrenergic receptor molecule

    Call: SONATA 5 , Panel: NZ2

    Principal investigator: dr Anita Płazińska

    Uniwersytet Medyczny w Lublinie, Wydział Farmaceutyczny z Oddziałem Analityki Medycznej

  13. Placebo mechanisms in voluntary joystick movement paradigm - factors influencing the formation and magnitude of the resu...

    Call: PRELUDIUM 5 , Panel: HS6

    Principal investigator: Karolina Świder

    Uniwersytet Jagielloński, Wydział Filozoficzny

  14. Elaboration of anti-cancer drug implantational delivery system immobilized on polymer matrix

    Call: OPUS 5 , Panel: ST5

    Principal investigator: dr Andrzej Plichta

    Politechnika Warszawska, Wydział Chemiczny

  15. Interaction of a potential anticancer agent, 3-bromopyruvic acid, with normal and malignant cells

    Call: OPUS 4 , Panel: NZ7

    Principal investigator: prof. Grzegorz Bartosz

    Uniwersytet Rzeszowski, Wydział Biologiczno-Rolniczy

  16. Structural studies based on low sequence similarity of G protein-coupled receptors activated by hormones and allosteric ...

    Call: SONATA 4 , Panel: NZ1

    Principal investigator: dr Dorota Latek

    Uniwersytet Warszawski, Wydział Chemii

  17. Antimicrobial prodrugs based on calixarenes

    Call: OPUS 4 , Panel: ST5

    Principal investigator: dr hab. Beata Korchowiec

    Uniwersytet Jagielloński, Wydział Chemii

  18. The role of dominant controlling functions over stimulation in cognitive performance in anxiety and depression.

    Call: SONATA BIS 2 , Panel: HS6

    Principal investigator: dr hab. Małgorzata Fajkowska

    Instytut Psychologii PAN

  19. The role of corticotropin releasing factor (CRF) in low and high anxiety rats, and teh iteraction between of the CRF sys...

    Call: OPUS 3 , Panel: NZ7

    Principal investigator: dr Anna Skórzewska

    Instytut Psychiatrii i Neurologii

  20. Evaluation of pharmacological activity of new, nonselective gamma-aminobutyric acid (GABA) transport inhibitors in some ...

    Call: OPUS 3 , Panel: NZ7

    Principal investigator: dr hab. Kinga Sałat

    Uniwersytet Jagielloński - Collegium Medicum, Collegium Medicum, Wydział Farmaceutyczny

  21. The influence of trait-anxiety on electrophysiological correlates of early stages of involuntary and voluntary emotional...

    Call: OPUS 2 , Panel: HS6

    Principal investigator: dr hab. Eligiusz Wronka

    UNIWERSYTET JAGIELLOŃSKI

  22. Study of supramolecular interaction between the xenoandrogens and androgen receptor

    Call: SONATA 2 , Panel: NZ7

    Principal investigator: dr hab. Michał Marszałł

    Uniwersytet Mikołaja Kopernika, Collegium Medicum im. Ludwika Rydygiera w Bydgoszczy, Wydział Farmaceutyczny

  23. Semaglutide and neurodevelopment: investigating risks arising from prenatal exposure to a widely popular drug for diabet...

    Call: OPUS 26 , Panel: NZ7

    Principal investigator: dr hab. Agnieszka Wnuk

    Instytut Farmakologii im. Jerzego Maja Polskiej Akademii Nauk

  24. Optogenetic and chemogenetic identification of brain circuits and cellular mechanisms underlying antidepressants resista...

    Call: OPUS 26 , Panel: NZ7

    Principal investigator: prof. Mariusz Papp

    Instytut Farmakologii im. Jerzego Maja Polskiej Akademii Nauk

  25. Synthesis, characterization, and evaluation of the biological activity of innovative thermosensitive suppositories compr...

    Call: OPUS 26 , Panel: NZ7

    Principal investigator: dr hab. Ewa Olędzka

    Warszawski Uniwersytet Medyczny, Wydział Farmaceutyczny

  26. Learner-internal factors in the Erasmus+ mobility context

    Call: OPUS 26 , Panel: HS2

    Principal investigator: dr hab. Katarzyna Ożańska-Ponikwia

    Uniwersytet Bielsko-Bialski

  27. Targeting adenylate kinase 4 (AK4) as a new paradigm in the treatment of non-small cell lung cancer: discovery and evalu...

    Call: OPUS 26 , Panel: NZ7

    Principal investigator: dr Magdalena Wujak

    Uniwersytet Mikołaja Kopernika w Toruniu, Collegium Medicum im. Ludwika Rydygiera w Bydgoszczy

  28. Design and characterisation of sealing materials of prosthetic obturator being additionally a cytostatic drug reservoir....

    Call: OPUS 26 , Panel: ST8

    Principal investigator: prof. Anna Trusek

    Politechnika Wrocławska

  29. Carbon quantum dots in the synthesis of functional polymeric materials using photoinduced atom transfer radical polymeri...

    Call: PRELUDIUM BIS 5 , Panel: ST5

    Principal investigator: prof. Paweł Chmielarz

    Politechnika Rzeszowska im. Ignacego Łukasiewicza, Wydział Chemiczny

  30. Development of bioresorbable polymer materials for the personalized ureteralstents releasing the antispasmodic drug

    Call: OPUS 25 , Panel: ST11

    Principal investigator: prof. Janusz Kasperczyk

    Centrum Materiałów Polimerowych i Węglowych Polskiej Akademii Nauk

  31. The cross-talk between 5-HTR2A and mGluR2 as a window for antidepressant effects of psilocybin.

    Call: OPUS 25 , Panel: NZ7

    Principal investigator: prof. Andrzej Pilc

    Instytut Farmakologii im. Jerzego Maja Polskiej Akademii Nauk

  32. Neuronal mechanisms of fear and anxiety control - the role of nucleus incertus to ventral hippocampus pathway in pattern...

    Call: OPUS 25 , Panel: NZ4

    Principal investigator: dr hab. Anna Błasiak

    Uniwersytet Jagielloński, Wydział Biologii

  33. Targeting the serotonin 5-HT7 receptor in a search for new strategies of mental disorders treatment

    Call: PRELUDIUM 22 , Panel: NZ7

    Principal investigator: Patryk Pyka

    Uniwersytet Jagielloński, Collegium Medicum

  34. Modeling of the excipients effect on drug skin permeability

    Call: PRELUDIUM 22 , Panel: NZ7

    Principal investigator: Laura Krumpholz

    Uniwersytet Jagielloński, Collegium Medicum

  35. Targeting nucleic acid-protein complexes with small molecules using a deep-learning framework

    Call: SONATINA 7 , Panel: NZ1

    Principal investigator: dr Ryhor Nikalayeu

    Międzynarodowy Instytut Biologii Molekularnej i Komórkowej w Warszawie

  36. Targeted poloxamer micelles with selected drugs as a strategy for overcoming the mechanisms of multidrug resistance in p...

    Call: PRELUDIUM BIS 4 , Panel: NZ7

    Principal investigator: prof. Tomasz Gośliński

    Uniwersytet Medyczny im. Karola Marcinkowskiego w Poznaniu

  37. Three-phase drug carriers - design towards a prolonged release, development of a transport model and its verification. C...

    Call: PRELUDIUM BIS 4 , Panel: ST8

    Principal investigator: prof. Anna Trusek

    Politechnika Wrocławska

  38. Model analysis of mass transfer of drug molecules through the bronchial mucus at different physiological states

    Call: PRELUDIUM 2 , Panel: ST8

    Principal investigator: Marcin Odziomek

    Politechnika Warszawska, Wydział Inżynierii Chemicznej i Procesowej

  39. Determinants of the relationship between olfaction and anxiety - psychophysical and physiological examination

    Call: PRELUDIUM 21 , Panel: HS6

    Principal investigator: Michał Pieniak

    Uniwersytet Wrocławski, Wydział Nauk Historycznych i Pedagogicznych

  40. Understanding drug/polymer/plasticizer miscibility and its effect on mechanical properties of polymeric filaments for FD...

    Call: PRELUDIUM 21 , Panel: NZ7

    Principal investigator: Marta Kozakiewicz-Latała

    Uniwersytet Medyczny im. Piastów Śląskich we Wrocławiu

  41. A comprehensive approach to powders for pharmaceutical 3D printing using Selective Laser Sintering - development of stra...

    Call: OPUS 23 , Panel: NZ7

    Principal investigator: dr hab. Piotr Kulinowski

    Uniwersytet Pedagogiczny im. Komisji Edukacji Narodowej w Krakowie

  42. Positive and negative emotions, engagement, motivation and attainment in English as a foreign language among Polish seco...

    Call: OPUS 23 , Panel: HS2

    Principal investigator: prof. Mirosław Pawlak

    Uniwersytet im. Adama Mickiewicza w Poznaniu, Wydział Pedagogiczno-Artystyczny w Kaliszu

  43. Bioresorbable, electrospun nonwoven as a multi-drug delivery system for a combination glioblastoma therapy

    Call: SONATA 17 , Panel: NZ7

    Principal investigator: dr Monika Musiał-Kulik

    Centrum Materiałów Polimerowych i Węglowych Polskiej Akademii Nauk

  44. Emotions and place change: consequences of climate change for well-being and pro-environmental behavior

    Call: SONATA 17 , Panel: HS6

    Principal investigator: dr Anna Wnuk

    Uniwersytet Warszawski, Wydział Psychologii

  45. ANSWER - ANxieties and Social coping strategies Within the last 50 years in the context of Natural EnviRonment: A Compar...

    Call: SONATA 17 , Panel: HS6

    Principal investigator: dr Krzysztof Mączka

    Uniwersytet im. Adama Mickiewicza w Poznaniu, Wydział Socjologii

  46. Development of new implantable drug forms, biodegradable nanofibers containing selected betulin derivatives in order to ...

    Call: OPUS 21 , Panel: NZ7

    Principal investigator: prof. Janusz Kasperczyk

    Śląski Uniwersytet Medyczny w Katowicach, Wydział Nauk Farmaceutycznych w Sosnowcu

  47. Dopaminergic modulation of high frequency oscillations in the rat olfactory bulb associated with the NMDA receptor hypof...

    Call: PRELUDIUM 20 , Panel: NZ4

    Principal investigator: Jacek Wróbel

    Instytut Biologii Doświadczalnej im. Marcelego Nenckiego Polskiej Akademii Nauk

  48. Thrombin binding aptamer with expanded chemical diversity as potential anticoagulant and anticancer agent

    Call: OPUS 21 , Panel: NZ7

    Principal investigator: dr Weronika Kotkowiak

    Instytut Chemii Bioorganicznej Polskiej Akademii Nauk

  49. The lipid fraction of the pulmonary surfactant enriched with fatty acids as a biomimetic drug carrier from the physicoch...

    Call: PRELUDIUM 20 , Panel: ST4

    Principal investigator: Martyna Krajewska

    Politechnika Poznańska, Wydział Technologii Chemicznej

  50. Selective inhibitors of γ-aminobutyric acid (GABA) transporter subtype 3 (GAT3) as a new pharmacological tools and a cha...

    Call: OPUS 21 , Panel: NZ7

    Principal investigator: dr Dawid Panek

    Uniwersytet Jagielloński, Collegium Medicum